MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Alpha-Synuclein and Mitochondria Quality Control in Parkinson’s Disease: A Literature Review

L. Shen (State College, USA)

Meeting: 2024 International Congress

Abstract Number: 926

Keywords: Alpha-synuclein, Mitochondria, Mitochondrial dysfunction

Category: Parkinson's Disease: Molecular Mechanisms of Disease

Objective: To provide an overview of the current knowledge on alpha-synuclein (αS) interactions with mitochondrial quality control (MQC) pathways in Parkinson’s disease (PD).

Background: The maintenance of healthy mitochondria is essential for neuronal survival and relies upon MQC pathways: mitochondrial biogenesis, dynamics, and autophagy. As mitochondrial dysfunction is critically implicated in PD, dysfunctional MQC may be central to PD pathology. Also at the heart of PD is αS, which forms PD’s hallmark Lewy bodies. Though many studies have examined mitochondria and αS, the mechanisms through which αS may influence MQC are not fully understood. Understanding these interactions may be essential to elucidating PD pathogenesis.

Method: A literature search was performed using PubMed to identify published studies on αS and MQC. The search was restricted to studies published in English. Titles and abstracts of search results were also screened for relevance.

Results: In mitochondrial biogenesis, αS may directly bind to PGC-1α’s promoter sequence, repressing PGC-1α’s normal function in regulating mitochondrial biogenesis. An excess of exogenous αS was also shown to interfere with Parkin’s degradation of PARIS, thus increasing PARIS-mediated transcriptional repression of PGC-1α. 

In mitochondrial fusion dynamics, overexpression of pathogenic αS may increase cleavage of the fusion protein OPA1, inducing mitochondrial fragmentation. In mitochondrial fission, αS may interact directly with mitochondrial membranes, as well as increase translocation of DRP1, a key fission protein, to mitochondria.

In mitochondrial autophagy, overexpressed αS may stabilize Miro proteins, interfering with the formation of mitochondrial-derived vesicles (MDVs) and delaying mitophagy initiation. αS may also reduce Parkin levels, negatively impacting MDV trafficking and autophagosome formation. By binding to spectrin, αS may excessively stabilize the actin cytoskeleton, disrupting autophagosome trafficking. Lastly, overexpressed αS may decrease SNAP29 activity, affecting the SNARE complex that mediates autophagosome-lysosome fusion.

Conclusion: There is yet to be widespread consensus on αS’s influence on MQC in PD, and future research is necessary to fully understand these mechanisms. Additionally, most research on αS and MQC has used overexpressed or pathological αS. Examining endogenous αS and MQC may provide further insight into αS’s influence on MQC.

To cite this abstract in AMA style:

L. Shen. Alpha-Synuclein and Mitochondria Quality Control in Parkinson’s Disease: A Literature Review [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/alpha-synuclein-and-mitochondria-quality-control-in-parkinsons-disease-a-literature-review/. Accessed May 21, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/alpha-synuclein-and-mitochondria-quality-control-in-parkinsons-disease-a-literature-review/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • The hardest symptoms that bother patients with Parkinson's disease
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley